Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder

Adriane Ribeiro Rosa; Benício N. Frey; Ana C. Andreazza; Keila M. Ceresér; Angelo B.M. Cunha; João Quevedo; Aida Santin; Carmem Gottfried; Carlos Alberto Gonçalves; Eduard Vieta; Flávio Kapczinski

doi:10.1016/j.neulet.2006.08.026

Back

Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder

Article 2006 en

Related publications

Article2022

Investigation of the effect of electroconvulsive treatment on serum glial cell line-derived neurotrophic factor levels in patients with schizophrenia and bipolar disorder

Mustafa Akkuş

Article2022

Glial Cell Line-Derived Neurotrophic Factor-Loaded CMCht/PAMAM Dendrimer Nanoparticles for Peripheral Nerve Repair

Ane Escobar, Mariana R. Carvalho, F. Raquel Maia, Rui L Reis, Tiago H. Silva, Joaquím M. Oliveira

Article2013

Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial

Iría Grande, Pedro Vieira da Silva Magalhães, Inês Chendo, Laura Stertz, Gabriel R. Fries, Keila Maria Mendes Ceresér, Angelo B.M. Cunha, Pedro Domingues Goi, Maurício Kunz, Marc Udina, Rocio Martín‐Santos, Benício N. Frey, Eduard Vieta, Flávio Kapczinski

Article2014

Delivery of chondroitinase ABC and glial cell line-derived neurotrophic factor from silk fibroin conduits enhances peripheral nerve regeneration

Wesley N. Sivak, James D. White, Jacqueline M. Bliley, Lee W. Tien, Han-Tsung Liao, David Kaplan, Kacey G. Marra

Article2012

Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder

Iría Grande, Flávio Kapczinski, Laura Stertz, Gabriela Delevati Colpo, Maurício Kunz, Keila M. Ceresér, Márcia Kauer-Sant’Anna, Benício N. Frey, Eduard Vieta, Pedro Vieira da Silva Magalhães

Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder

Discussion(0)

Related publications

Investigation of the effect of electroconvulsive treatment on serum glial cell line-derived neurotrophic factor levels in patients with schizophrenia and bipolar disorder

Glial Cell Line-Derived Neurotrophic Factor-Loaded CMCht/PAMAM Dendrimer Nanoparticles for Peripheral Nerve Repair

Val66Met polymorphism and serum brain‐derived neurotrophic factor in bipolar disorder: an open‐label trial

Delivery of chondroitinase ABC and glial cell line-derived neurotrophic factor from silk fibroin conduits enhances peripheral nerve regeneration

Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder